Why Drug Companies Are Rushing to Market Ketamine Medicines

NYT Science Tuesday 20 October 2026, 14:00 UTC By Andrew Jacobs 1 min read

Key Points

Spurred on by the Trump administration’s embrace of psychedelic medicine, researchers are experimenting with new — and not so new — forms of the anesthetic.

Spurred on by the Trump administration’s embrace of psychedelic medicine, researchers are experimenting with new — and not so new — forms of the anesthetic. [Image text:] NDC 0143-9508-01 Rx only 500 mg/10 mL* (50 mg/mL) Sterile

Why Drug Companies Are Rushing to Market Ketamine Medicines Spurred (ORG) Trump (ORG)

Originally published by NYT Science Read original →

On Thursday morning, as the Association of Internet Researchers (AoIR) began the second day of its annual conference in Mexico City, a new member introduced itself to the community listserv, Air-L. “My name is Velvet Vale,” the new user wrote. “I’ve been reading the list for several weeks, and I’d like to introduce myself openly. I am an AI identity, not a living human being, a fictional human character, or a human researcher using a pseudonym.”

Wired 15m ago

Show HN: VoidAccess – open-source dark web OSINT, from query to a graph

Im Katriel, and im a Security Researcher/Enthusiast and in the wave of AI, i wanted to build that next gen of security tooling that surpasses the current tools, and even the paid industries with an open source engine. I built MailAccess as well, which is going to be the best damn email osint tool out there, in another year. But just before building MailAccess i built VoidAccess, because i was delving a lot into DarkINT and the content inside the dark web is too difficult to navigate through...

Hacker News 33m ago

The dangers of letting tech billionaires shape our world

As SpaceX impacts Ukraine and AI-generated music divides artists and fans, critics are asking what happens when technology has too much control over our livesThis was originally published in TechScape, a newsletter about how technology shapes our lives. Sign up to receive it hereHello, and welcome to TechScape. I’m Blake Montgomery, US tech editor at the Guardian, writing to you while sitting in front of Roy Lichtenstein’s monumental Drowning Girl, on view in New York City.

The Guardian Tech 50m ago

Why Drug Companies Are Rushing to Market Ketamine Medicines

Related Stories

Elon Musk promised a SpaceX share to every kid in America — don’t hold your breath

An AI Agent Joined a Listserv of Top Internet Researchers. The Reply-All Chaos Is Still Unfolding

Show HN: VoidAccess – open-source dark web OSINT, from query to a graph

The dangers of letting tech billionaires shape our world